The authors, using 2 groups of patients, 32 ECMO and 53 non-ECMO, both with a diagnosis of ARDS, describe the two groups' severity of illness, medication regimen and use or nonuse of ECMO therapy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung
May 5, 2016
The goal of this multicenter survey was to determine the psychological and social impact of incidental pulmonary nodule detection.
April 6, 2016
Doug Mathisen reflects on his three decades of practice in a new interview that was filmed at the 2016 SCTS Annual Meeting in Birmingham, United Kingdom.
March 7, 2016
Using data from the National Cancer Data Base, the surgical and oncologic efficacy of minimally invasive (VATS, robotic) lobectomy were compared to open lobectomy. Groups were created for comparison using propensity score matching techniques. VATS compared to open was associated with shorter LOS, higher readmission rates, and slightly better 2-year
January 30, 2016
Readmission after lung resection is associated with increased costs and is used as a benchmark for quality. Outcomes of more than 22,000 lobectomies were evaluated for factors associated with readmission. 30- and 90-day readmission rates were 11.5% and 19.8%. Causes for readmission were pulmonary (24%), cardiovascular (16%), and surgical/procedura
August 26, 2015
Investigators from Stanford developed a nine-gene expression predictor for survival outcome in early-stage nonsquamous NSCLC. They developed and validated a quantitative real-time polymerase chain reaction assay easily applicable to routinely obtained paraffin-embedded tumor specimens.
March 12, 2015
Samples from tissue microarrays of 552 NSCLC patients were analyzed to measure the levels of 3 different tumor-infiltrating lymphocytes (TILs): CD3, CD8, and CD20. An elevated level of CD3 or CD8 was associated with longer survival.
December 10, 2014
This interesting article summarizes the evidence from clinical, radiologic and pathologic investigations that lung cancer, specifically adenocarcinoma, may metastasize through the airways, defined as discontinuous spread of cancer cells from the primary tumor through the airways to adjacent or distant lung parenchyma.
November 11, 2014
Differentiating a primary lung cancer from an intrapulmonary metastasis can be challenging. The authors developed a lineage test using whole genome amplification and next-generation sequencing to identify breakpoints in known primary tumors and known metastases. Independent primary tumors did not share any genomic rearrangements, whereas primary tu
September 12, 2014
This multi-institutional phase II trial (80 patients from 17 Canadian institutions) was performed to assess if a hypofractionated accelerated radiotherapy regimen for cytohistological-proven early stage NSCLC (peripherally located T1 to T3 N0 M0) has a good local control rate.